2025-01-01 2025-12-31 false Capium Accounts Production 1.1 13801418 2025-01-01 2025-12-31 13801418 bus:FullAccounts 2025-01-01 2025-12-31 13801418 bus:FRS102 2025-01-01 2025-12-31 13801418 bus:AuditExemptWithAccountantsReport 2025-01-01 2025-12-31 13801418 bus:SmallCompaniesRegimeForAccounts 2025-01-01 2025-12-31 13801418 bus:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 13801418 2025-01-01 2025-12-31 13801418 2025-12-31 13801418 bus:RegisteredOffice 2025-01-01 2025-12-31 13801418 core:WithinOneYear 2025-12-31 13801418 core:AfterOneYear 2025-12-31 13801418 1 2025-01-01 2025-12-31 13801418 bus:Director1 2025-01-01 2025-12-31 13801418 bus:Director1 2025-12-31 13801418 bus:Director1 2024-01-01 2024-12-31 13801418 2024-01-01 13801418 bus:LeadAgentIfApplicable 2025-01-01 2025-12-31 13801418 2024-01-01 2024-12-31 13801418 2024-12-31 13801418 core:WithinOneYear 2024-12-31 13801418 core:AfterOneYear 2024-12-31 13801418 bus:EntityAccountantsOrAuditors 2024-01-01 2024-12-31 13801418 core:ComputerEquipment 2025-01-01 2025-12-31 13801418 core:ComputerEquipment 2025-12-31 13801418 core:ComputerEquipment 2024-12-31 13801418 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2025-12-31 13801418 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-12-31 13801418 core:CostValuation core:Non-currentFinancialInstruments 2025-12-31 13801418 core:CostValuation core:Non-currentFinancialInstruments 2024-12-31 13801418 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-12-31 13801418 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-12-31 13801418 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-12-31 13801418 core:Non-currentFinancialInstruments 2025-12-31 13801418 core:Non-currentFinancialInstruments 2024-12-31 13801418 core:ShareCapital 2025-12-31 13801418 core:ShareCapital 2024-12-31 13801418 core:RetainedEarningsAccumulatedLosses 2025-12-31 13801418 core:RetainedEarningsAccumulatedLosses 2024-12-31 13801418 dpl:Item1 2025-01-01 13801418 dpl:Item1 2025-12-31 13801418 dpl:Item1 2024-01-01 13801418 dpl:Item1 2024-12-31 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 13801418
England and Wales

 

 

 

PGS MEDICS LTD



Unaudited Financial Statements
 


Period of accounts

Start date: 01 January 2025

End date: 31 December 2025
Director Patrick George Stephen
Registered Number 13801418
Registered Office 65 Peach Street
Wokingham
Berkshire
RG40 1XP
1
Director's report and financial statements
The director presents his annual report and the financial statements for the year ended 31 December 2025.
Principal activities
Principal activity of the company during the financial year was of general medical practice activities.
Director
The director who served the company throughout the year was as follows:
Patrick George Stephen

On behalf of the board.


----------------------------------
Patrick George Stephen
Director

Date approved: 12 June 2026
2
 
 
Notes
 
2025
£
  2024
£
Fixed assets      
Tangible fixed assets 3 776    222 
776    222 
Current assets      
Debtors 4 14,763    46,605 
Cash at bank and in hand 233    1,393 
14,996    47,998 
Creditors: amount falling due within one year 5 (12,190)   (48,246)
Net current assets 2,806    (248)
 
Total assets less current liabilities 3,582    (26)
Provisions for liabilities 6 (194)   36 
Net assets 3,388    10 
 

Capital and reserves
     
Called up share capital 1    1 
Profit and loss account 3,387    9 
Shareholders' funds 3,388    10 
 


For the year ended 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
  2. The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies.
The financial statements were approved by the director on 12 June 2026 and were signed by:


-------------------------------
Patrick George Stephen
Director
3
General Information
PGS Medics Ltd is a private company, limited by shares, registered in England and Wales, registration number 13801418, registration address 65 Peach Street, Wokingham, Berkshire, RG40 1XP.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in accordance with Financial Reporting Standard 102"The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.
The financial statements are prepared in sterling which is the functional currency of the company.
Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.
Taxation
Taxation represents the sum of tax currently payable and deferred tax. Tax is recognised in the statement of income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves.
The company’s liability for current tax is calculated using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Current and deferred tax assets and liabilities are not discounted
Deferred taxation
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the reporting date.

Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Current and deferred tax assets and liabilities are not discounted.
Tangible fixed assets
Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
Computer Equipment 33% Reducing Balance
Provisions
Provisions are recognised when the company has a present obligation as a result of a past event which it is more probable than not will result in an outflow of economic benefits that can be reasonably estimated.
2.

Average number of employees

Average number of employees during the year was 0 (2024 : 0).
3.

Tangible fixed assets

Cost or valuation Computer Equipment   Total
  £   £
At 01 January 2025 749    749 
Additions 719    719 
Disposals  
At 31 December 2025 1,468    1,468 
Depreciation
At 01 January 2025 527    527 
Charge for year 165    165 
On disposals  
At 31 December 2025 692    692 
Net book values
Closing balance as at 31 December 2025 776    776 
Opening balance as at 01 January 2025 222    222 


4.

Debtors: amounts falling due within one year

2025
£
  2024
£
Trade Debtors 5,102    9,062 
Prepayments & Accrued Income 188   
Taxation recoverable 9,473    9,473 
Directors' Current Accounts   28,070 
14,763    46,605 

5.

Creditors: amount falling due within one year

2025
£
  2024
£
Social Security and Other Taxes 12,190   
PAYE & Social Security   48,246 
12,190    48,246 

6.

Provisions for liabilities

2025
£
  2024
£
Deferred Tax 194    (36)
194    (36)

7.

Advances and Credits



Patrick George Stephen
The following advances and credits to a director subsisted during the years ended 31 December 2025 and 31 December 2024:

Current year (2025)
Brought Forward
£
Amount
£
Interest
£
Repaid
£
Written Off
£
Waived
£
Carry Forward
£
Patrick George Stephen28,070 29,655 57,725 
28,070 29,655 57,725 
Previous year (2024)
Brought Forward
£
Amount
£
Interest
£
Repaid
£
Written Off
£
Waived
£
Carry Forward
£
Patrick George Stephen8,716 27,492 8,138 28,070 
8,716 27,492 8,138 28,070 
4